Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
26
RCUS Quote, Financials, Valuation and Earnings
Last price:
$23.11
Seasonality move
:
-9.85%
Day range:
$22.53 - $23.16
52-week range:
$6.50 - $26.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
9.71x
P/B ratio:
6.56x
Volume:
444.8K
Avg. volume:
2.1M
1-year change:
45.32%
Market cap:
$2.9B
Revenue:
$258M
EPS (TTM):
-$3.43
Earnings Data
Next earnings date for RCUS
Feb 24
2026
Most recent earnings per share
-$1.27
Beat by $0.02
(Oct 28/2025)
Consensus Estimate
-$1.29
(Oct 28/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RCUS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/24/2026 | Q4 | $24.8M | -- | -- | -$1.08 | -- |
| 10/28/2025 | Q3 | $20.3M | $26M | -$1.27 | -$1.29 | $0.02 |
| 08/08/2025 | Q2 | $32.9M | $160M | -- | -$1.17 | -- |
| 05/07/2025 | Q1 | $38.6M | $28M | -$1.14 | -$1.08 | -$0.06 |
| 02/25/2025 | Q4 | $28.6M | $26M | -$1.03 | -$1.20 | $0.18 |
| 11/06/2024 | Q3 | $39M | $48M | -$1.01 | -$1.07 | $0.06 |
| 08/08/2024 | Q2 | $26.5M | $39M | -$1.02 | -$1.39 | $0.36 |
| 05/08/2024 | Q1 | $28.8M | $145M | -$0.05 | -$0.77 | $0.72 |
| 02/21/2024 | Q4 | $28.3M | $31M | -$1.08 | -$1.00 | -$0.08 |
| 11/07/2023 | Q3 | -- | $32M | -$0.95 | -- | -- |
| 08/07/2023 | Q2 | -- | $29M | -$1.02 | -- | -- |
| 05/09/2023 | Q1 | -- | $25M | -$1.10 | -- | -- |
| 02/28/2023 | Q4 | -- | $33.7M | -$0.93 | -- | -- |
| 11/02/2022 | Q3 | -- | $33.6M | -$0.90 | -- | -- |
| 08/03/2022 | Q2 | -- | $26.8M | -$0.93 | -- | -- |
| 05/09/2022 | Q1 | -- | $18M | -$0.96 | -- | -- |
| 02/23/2022 | Q4 | -- | $354.5M | $3.71 | -- | -- |
| 11/08/2021 | Q3 | -- | $9.5M | -$1.11 | -- | -- |
| 08/05/2021 | Q2 | -- | $9.5M | -$1.09 | -- | -- |
| 05/05/2021 | Q1 | -- | $9.5M | -$1.08 | -- | -- |
| 02/24/2021 | Q4 | -- | $9.5M | -$0.82 | -- | -- |
| 11/05/2020 | Q3 | -- | $64.5M | $0.03 | -- | -- |
| 08/06/2020 | Q2 | -- | $1.8M | -$0.93 | -- | -- |
| 05/05/2020 | Q1 | -- | $1.8M | -$0.63 | -- | -- |
| 03/05/2020 | Q4 | -- | $9.8M | -$0.38 | -- | -- |
| 11/05/2019 | Q3 | -- | $1.8M | -$0.51 | -- | -- |
| 08/06/2019 | Q2 | -- | $1.8M | -$0.64 | -- | -- |
| 05/02/2019 | Q1 | -- | $1.8M | -$0.41 | -- | -- |
| 03/05/2019 | Q4 | -- | $1.6M | -$0.28 | -- | -- |
| 11/08/2018 | Q3 | -- | $4.3M | -$0.25 | -- | -- |
| 08/06/2018 | Q2 | -- | $1.3M | -$0.32 | -- | -- |
| 03/31/2018 | Q1 | -- | $1.3M | -$1.37 | -- | -- |
| 12/31/2017 | Q4 | -- | $1.3M | -$0.30 | -- | -- |
| 09/30/2017 | Q3 | -- | $163K | -$11.86 | -- | -- |
Arcus Biosciences, Inc. Earnings Questions
-
How Much did Arcus Biosciences, Inc. Generate in Revenue Last Quarter?
Arcus Biosciences, Inc. reported $26M worth of top line sales in its most recent quarter.
-
Did Arcus Biosciences, Inc. Beat Earnings Last Quarter?
Arcus Biosciences, Inc. announced earnings per share of -$1.27 which represents a beat of analyst forecast a -$1.29 per share.
-
Is Arcus Biosciences, Inc. Profitable?
Arcus Biosciences, Inc. reported $24M that represents $0.23 per share over the last quarter.
-
What is the Analyst Consensus for Arcus Biosciences, Inc. EPS Next Year?
Arcus Biosciences, Inc.'s earnings are forecast to decrease from -$3.14 per share to -$3.24 per share next year representing a decrease of -11.43%.
-
When is Arcus Biosciences, Inc.'s Earnings Date?
Arcus Biosciences, Inc.'s next earnings date is February 24, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
